Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

19

Portfolio Exits

6

About Lotus Biosciences

Lotus Biosciences is a Hong Kong based venture capital firm.

Lotus Biosciences Headquarter Location

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Lotus Biosciences Investments

19 Investments

Lotus Biosciences has made 19 investments. Their latest investment was in Humanigen as part of their Series D on December 12, 2008.

CBI Logo

Lotus Biosciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/18/2008

Series D

Humanigen

$32M

No

2

7/25/2007

Series C

Humanigen

$20M

No

1

5/4/2007

Series D

AVEO Oncology

$53M

Yes

3/15/2006

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

8/8/2005

Unattributed VC - IV

Subscribe to see more

$99M

Subscribe to see more

0

Date

12/18/2008

7/25/2007

5/4/2007

3/15/2006

8/8/2005

Round

Series D

Series C

Series D

Unattributed VC

Unattributed VC - IV

Company

Humanigen

Humanigen

AVEO Oncology

Subscribe to see more

Subscribe to see more

Amount

$32M

$20M

$53M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

0

0

Lotus Biosciences Portfolio Exits

6 Portfolio Exits

Lotus Biosciences has 6 portfolio exits. Their latest portfolio exit was Humanigen on January 31, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/31/2013

IPO

$99M

Public

2

3/12/2010

IPO

Subscribe to see more

$99M

Subscribe to see more

0

2/11/2008

IPO

Subscribe to see more

$99M

Subscribe to see more

0

4/12/2006

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

6/2/2005

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

1/31/2013

3/12/2010

2/11/2008

4/12/2006

6/2/2005

Exit

IPO

IPO

IPO

Reverse Merger

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

0

0

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.